適用於公開取用強制性政策的文章 - Tamer Elbaz瞭解詳情
未在任何資料庫公開的文章：1
Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma
SS Youssef, RE El-Araby, EAER Abbas, M Hassany, T Elbaz
Expert Review of Molecular Diagnostics 23 (3), 267-278, 2023
授權規定： US National Institutes of Health
在某個資料庫公開的文章：3
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium
JD Yang, EA Mohamed, AOA Aziz, HI Shousha, MB Hashem, MM Nabeel, ...
The lancet Gastroenterology & hepatology 2 (2), 103-111, 2017
授權規定： US National Institutes of Health
Survival and recurrence rates of hepatocellular carcinoma after treatment of chronic hepatitis C using direct acting antivirals
RM Lithy, T Elbaz, AH Abdelmaksoud, MM Nabil, N Rashed, D Omran, ...
European Journal of Gastroenterology & Hepatology 34 (2), 227-234, 2022
授權規定： American Heart Association
The Core/E1 domain of hepatitis C virus genotype 4a in Egypt does not contain viral mutations or strains specific for hepatocellular carcinoma
X Zhang, SH Ryu, Y Xu, T Elbaz, ARN Zekri, AO Abdelaziz, ...
Journal of clinical virology 52 (4), 333-338, 2011
授權規定： US National Institutes of Health
出版品和資金資訊是由電腦程式自動估算而得